Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-10-16

FDA Approved: CROMOLYN SODIUM INHALATION SOLUTION — Original Application (Ritedose Pharmaceuticals, LLC)

View source ↗

Summary

The FDA approved an original ANDA for cromolyn sodium inhalation solution from Ritedose Pharmaceuticals, enabling a generic version of the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cromolyn sodium inhalation solution (Cromolyn sodium inhalation solution)

Snippet

ORIG AP for CROMOLYN SODIUM INHALATION SOLUTION (CROMOLYN SODIUM INHALATION SOLUTION)